ISDA

Entry Detail

PDB ID:

3P89

Keywords:

TRANSCRIPTION/INHIBITOR

Title:

FXR bound to a quinolinecarboxylic acid

Biological Source:

Source Organism:

Homo sapiens

Host Organism:

Escherichia coli

PDB Version:

Deposition Date:

2010-10-13

Release Date:

2011-08-31

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.30 Å

R-Value Free:

0.25

R-Value Work:

0.22

R-Value Observed:

0.22

Space Group:

F 2 3

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:Farnesoid X receptor
Mutations:C432E, C466E
Chain IDs:A
Chain Length:229
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:Q96RI1 Pfam ID:PF00104 EC:2.3.1.48

Protein Blast

Polymer Type:polypeptide(L)
Description:Nuclear receptor coactivator 1
Chain IDs:B
Chain Length:11
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:Q15788 EC:2.3.1.48

Ligand Molecules

89P

SO4

Primary Citation

Conformationally constrained farnesoid X receptor (FXR) agonists: Heteroaryl replacements of the naphthalene.

Bass, J.Y, Caravella, J.A, Chen, L, Creech, K.L, Deaton, D.N, Madauss, K.P, Marr, H.B, McFadyen, R.B, Miller, A.B, Mills, W.Y, Navas, F, Parks, D.J, Smalley, T.L, Spearing, P.K, Todd, D, Williams, S.P, Wisely, G.B.Show

Bioorg.Med.Chem.Lett. 21 1206 1213 (2011)

PMID: 21256005 DOI: 10.1016/j.bmcl.2010.12.089

Abstact

To improve on the drug properties of GSK8062 1b, a series of heteroaryl bicyclic naphthalene replacements were prepared. The quinoline 1c was an equipotent FXR agonist with improved drug developability parameters relative to 1b. In addition, analog 1c lowered body weight gain and serum glucose in a DIO mouse model of diabetes.

Legend

Protein

Chemical

Disease

Primary Citation of related structures